Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Cancer Immunol Res. 2017 Jul 3;5(8):685–694. doi: 10.1158/2326-6066.CIR-16-0330

Figure 4. Anti-tumor effect of anti-CTLA-4 and SS1P depends on CD8+ T cells.

Figure 4

(A) Individual growth curves of 66C14-M tumors treated with anti-CTLA-4 (thin arrows) and SS1P (thick arrows) and 100 μg anti-CD8 antibody given i.p on days 1, 2, 6, 10 and 14. (B) Growth curves of tumors treated with SS1P and anti-CTLA-4. (C) Long-term survival of mice. The number of mice in complete remission and total mice per group is shown in parentheses. P < 0.05.